View Post

Scientists link proteins that keep cells multiplying to cancer

In In The News by Barbara Jacoby

By: Catharine Paddock PhD From: medicalnewstoday.com Cancer is a disease where cells become abnormal and multiply out of control. Until now it was thought the proliferation of cancer cells was controlled by transcription factor proteins. But now a new study suggests another family of proteins may also be involved. The study – led by the Massachusetts Institute of Technology (MIT) …

Nanoparticles cause cancer cells to self-destruct

In In The News by Barbara Jacoby

Using magnetically controlled nanoparticles to force tumour cells to ‘self-destruct’ sounds like science fiction, but could be a future part of cancer treatment, according to research from Lund University in Sweden. “The clever thing about the technique is that we can target selected cells without harming surrounding tissue. There are many ways to kill cells, but this method is contained …

ViewRay™ Announces World’s First Patients Treated Using MRI-Guided Radiation Therapy

In In The News by Barbara Jacoby

The ViewRay™ system, the world’s first and only MRI-guided radiation therapy system, is being used to treat patients at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Mo. The ViewRay system provides a patented combination of simultaneous radiation therapy delivery and continuous magnetic resonance imaging (MRI) for the treatment of cancer. MRI-guided radiation …

A Breakthrough Bioelectronic Medical Approach to Cancer Treatment

In In The News by Barbara Jacoby

Cancer-Code Corporation (C3) announces the issuance of U.S. Patent No. 8,656,930 on February 25, 2014. The ‘930 patent, entitled “Method and System for Processing Cancer Cell Electrical Signals for Medical Therapy,” covers a breakthrough technological approach to eradicating cancer in humans and animals. This is a foundation patent in the burgeoning field of bioelectronic medical applications, specifically for treating cancer …

New drug candidate from Vivolux starves cancer cells – clinical study due to begin shortly

In In The News by Barbara Jacoby

Vivolux AB, a drug discovery company specialized in cancer treatment, announced today that data that forms the basis for one of the company’s promising projects has been published in the journal Nature Communications. Researchers at Vivolux have discovered a novel cancer drug target. The drug candidate kills sleeping cell populations in regions of solid tumors that are less oxygenized – …

New Breast Cancer Surgical Guideline Offers Cost- and Life-Improving Recommendations

In In The News by Barbara Jacoby

The Society of Surgical Oncology (SSO) is proud to announce the release of a comprehensive consensus guideline for physicians treating breast cancer that will reduce healthcare costs and improve the course of treatment. Developed in conjunction with the American Society of Radiation Oncology (ASTRO), it outlines an evidence-based surgical treatment path that will save patients from unnecessary surgery. “A significant …

Stress: A Cause Of Breast Cancer?

In In The News by Barbara Jacoby

By Peter Zafirides, M.D. Ohio State University researchers say the study suggests a specific gene, called ATF3, may be the crucial link between stress and cancer, including metastasis – the major cause of cancer death. Previous public health studies have shown that stress is a risk factor for cancer. Researchers already know that ATF3 is activated, or expressed, in response …

Stress: A Cause Of Breast Cancer?

In In The News by Barbara Jacoby

By Peter Zafirides, M.D. Ohio State University researchers say the study suggests a specific gene, called ATF3, may be the crucial link between stress and cancer, including metastasis – the major cause of cancer death. Previous public health studies have shown that stress is a risk factor for cancer. Researchers already know that ATF3 is activated, or expressed, in response …

Nontoxic cancer therapy proves effective against metastatic cancer

In In The News by Barbara Jacoby

A combination of nontoxic dietary and hyperbaric oxygen therapies effectively increased survival time in a mouse model of aggressive metastatic cancer, a research team from the Hyperbaric Biomedical Research Laboratory at the University of South Florida has found. The study, “The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer,” was published online today in …

Sanford-Burnham researchers map a new metabolic pathway involved in cell growth and implicated in cancer as well as metabolic disorders

In In The News by Barbara Jacoby

Deciphering the body’s complex molecular pathways that lead to disease when they malfunction is highly challenging. Researchers at Sanford-Burnham Medical Research Institute now have a more complete picture of one particular pathway that can lead to cancer and diabetes. In the study published by Molecular Cell, the scientists uncovered how a protein called p62 has a cascade affect in regulating …